CannPal Animal Therapeutics Limited, an animal health company, engages in the research and development of plant-based therapeutic products for pets in Australia. It develops CPAT-01, a cannabis-derived pharmaceutical product to provide veterinarians and pet owners to treat pain and inflammation in dogs. The company was incorporated in 2016 and is based in Double Bay, Australia. As of March 11, 2021, CannPal Animal Therapeutics Limited operates as a subsidiary of AusCann Group Holdings Ltd.
What is CannPal Animal Therapeutics Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange CannPal Animal Therapeutics Limited stocks are traded under the ticker 41C.STU.
In which sector is CannPal Animal Therapeutics Limited located?▼
CannPal Animal Therapeutics Limited operates in the Other sector.
When did CannPal Animal Therapeutics Limited complete a stock split?▼
CannPal Animal Therapeutics Limited has not had any recent stock splits.